A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Clinical trial NCT01364727 · COMPLETED
Trial details
- NCT number
- NCT01364727
- Sponsor
- Heather Wakelee
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2014-07-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.